Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Long-term Safety of Dupilumab in Children 2 to <6 Years of Age with Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze

Project: Research

Project Details

StatusActive
Effective start/end date02/29/24 → 01/16/27

Funding

  • Sanofi US Services Incorporated: $44,280.40